Epirubitec 50 mg Injection
24,31$
18,96$
Epirubitec 50 mg injection is a potent chemotherapy agent designed to combat a variety of cancers, including but not limited to breast, stomach, lung, and ovarian cancers, as well as blood cancers and soft-tissue sarcomas. This medication works by inhibiting the growth and proliferation of cancer cells, thereby helping to control the spread of tumors throughout the body. While Epirubitec is a vital option for many adult patients facing these challenging diagnoses, it is important to note that its safety and efficacy have not been evaluated in children. Patients receiving this treatment should be closely monitored for potential side effects and adverse reactions. As with any anti-cancer therapy, discussing the benefits and risks with a healthcare provider is crucial for optimal treatment planning. By targeting cancerous cells, Epirubitec plays an essential role in modern oncology, offering hope to those affected by aggressive malignancies. Always consult your doctor for personalized medical advice and to understand how this injection may fit into your overall treatment strategy.
Quantité
Active Pharmaceutical Ingredient
Uses
• Epirubitec 50 mg injection is utilized in the treatment of breast cancer. This condition may present with symptoms such as a noticeable lump in the breast, changes in breast shape, or unusual nipple discharge. The medication targets rapidly dividing cancer cells, helping to slow down their growth. It is often administered as part of a comprehensive treatment plan for patients diagnosed with breast cancer.
• The injection is also effective for managing gastric cancer. Patients may experience symptoms like stomach pain, nausea, and unintentional weight loss. Epirubitec 50 mg injection works by disrupting the cancer cell cycle, which can help alleviate some of the symptoms associated with this type of cancer. It is commonly used in conjunction with other therapies to enhance treatment outcomes.
• In cases of head and neck cancer, Epirubitec 50 mg injection plays a significant role in treatment. Symptoms can include persistent sore throats and difficulty swallowing, which can severely affect a patient's quality of life. By targeting cancer cells, this medication aims to reduce tumor size and improve symptoms. It is an important option for patients undergoing therapy for head and neck malignancies.
• Epirubitec 50 mg injection is also prescribed for liver cancer treatment. Common symptoms may include abdominal discomfort and jaundice, which can indicate the progression of the disease. The drug acts on cancerous cells within the liver, potentially leading to a reduction in symptoms and improved overall health. It is frequently part of a multi-faceted approach to managing liver cancer effectively.
Benefits
Breast cancer: Breast cancer is a type of cancer that begins in the breast tissue. This cancer can start in different parts of the breast, such as the milk ducts, lobules, or connective tissue. Epirubitec 50 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated. Stomach cancer: stomach cancer, also known as gastric cancer, is a type of cancer that begins in the cells of the stomach lining. Symptoms may include indigestion, heartburn, stomach pain or discomfort, bloating, nausea or vomiting, loss of appetite, unintentional weight loss, and black or bloody stools. Epirubitec 50 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Neck and Head Cancer: Head and neck cancer includes cancer of the mouth, nose, sinuses or throat. Epirubitec 50 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective medicine but it has some bothersome side effects. Therefore, you should discuss the risks and benefits with your doctor. Liver cancer: liver cancer, also known as hepatic carcinoma, is a type of cancer that begins in the cells of the liver. Symptoms of hepatic carcinoma may include abdominal pain or discomfort, loss of appetite, weight loss, fatigue, nausea or vomiting, yellowing of the skin or eyes (jaundice), and swelling in the abdomen or legs. Epirubitec 50 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Blood cancer: blood cancer is a type of cancer that affects the blood and bone marrow. Symptoms of blood cancer may include fatigue, weakness, fever, night sweats, weight loss, easy bruising or bleeding, frequent infections, and bone pain. Epirubitec 50 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells.
Lung cancer: Lung cancer is a type of cancer that begins in the lungs. The main cause of lung cancer is cigarette smoking, but exposure to other environmental factors such as air pollution, radon gas, and workplace exposure to certain chemicals and substances can also increase the risk of developing lung cancer. Epirubitec 50 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated. Malignant lymphomas: Malignant lymphomas are a group of cancers that affect the lymphatic system, which is part of the immune system. The lymphatic system includes lymph nodes, the spleen, the thymus, and bone marrow, among other tissues. Epirubitec 50 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Ovarian cancer: Ovarian cancer is a type of cancer that begins in the ovaries, which are the female reproductive organs that produce eggs. Symptoms of ovarian cancer may include abdominal swelling or bloating, pelvic pain, difficulty eating or feeling full quickly, frequent urination, and changes in bowel habits. Epirubitec 50 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated. Pancreatic cancer: Pancreatic cancer is a type of cancer that occurs in the pancreas, an organ located behind the stomach that plays a crucial role in digestion and blood sugar regulation. Symptoms of pancreatic cancer may include abdominal pain, jaundice (yellowing of the skin and eyes), weight loss, loss of appetite, nausea, and vomiting. Epirubitec 50 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Colorectal cancer: Sigmoid-rectal carcinoma, also known as colorectal cancer, is a type of cancer that occurs in the colon or rectum, which are parts of the large intestine.Symptoms of sigmoid-rectal carcinoma may include changes in bowel habits, such as diarrhoea or constipation, rectal bleeding, abdominal pain or cramping, unexplained weight loss, and fatigue. Epirubitec 50 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Soft-tissue sarcomas: Soft-tissue sarcomas are a group of cancers that originate in the soft tissues of the body, such as muscle, fat, nerves, tendons, and cartilage. Soft tissue sarcomas can occur anywhere in the body, but they most commonly develop in the limbs, trunk, or abdomen. Epirubitec 50 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.
Side Effects
Most adverse effects do not require medical attention and will go away when your body gets used to the medicine. Inform your doctor if any of these symptoms get severe or that bother you for a longer period.
Most Common Side Effects
• Hyper Pigmentation in Nail Skin
• Appetite Loss
• Ulcers
• Pain in the Abdomen
• Vomiting
• Nausea
• Flushing
• Hair Loss
Common Side Effects
• Anaemia
• Dehydration
• Cardiac Problems
• Diarrhoea
• Conjunctivitis
• Inflammation
• Amenorrhea
• Lows levels of Blood Count
How To Use
Epirubitec 50 mg Injection is administered by a doctor or nurse at a hospital or clinical setting. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to. You should avoid drinking alcohol as it may increase your risk of liver damage. Do not self-administered this Epirubitec 50 mg.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Epirubitec 50 mg. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Epirubitec 50 mg Injection is considered safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Epirubitec 50 mg may not be needed in these patients. Please consult your doctor. Lower doses may be considered in patients with serum creatinine > 5 mg/dL.
• Breastfeeding: It is not known whether Epirubitec 50 mg Injection is excreted in human milk. Because many drugs, including other anthracyclines, are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Epirubicin, lactating women should be advised not to breastfeed during treatment with Epirubitec 50 mg and for at least 7 days after last dose.
• Liver: Epirubitec 50 mg is recommended for use in patients with mild to moderate liver disease. No dose adjustment is needed in such types of patients. In case patients suffer from severe liver disease, the use of this medicine in such types of people is not recommended, It may worsen the patient's condition.
• Pregnancy: Use of Epirubitec 50 mg Injection may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Epirubitec 50 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Epirubitec 50 mg Injection has not any effect on the ability to drive or use machinery.